Journal article icon

Journal article

Vortioxetine for depression: the evidence for its current use in the UK: Commentary on... Cochrane Corner

Abstract:

The pharmacological treatment of depression is often hampered by side-effects and unsatisfactory response to treatment. Vortioxetine is one of the newest antidepressants on the market, purportedly with a different mechanism of action compared with other antidepressants. This month's Cochrane Corner review examines the evidence available for the use of vortioxetine as a first-line treatment for depression in adults. This commentary puts the Cochrane review's findings into their clinical contex...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1192/bja.2018.62

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Psychiatry
Oxford college:
Brasenose College
ORCID:
0000-0001-5984-8696
Publisher:
Cambridge University Press Publisher's website
Journal:
BJPsych Advances Journal website
Volume:
25
Issue:
1
Pages:
3-6
Publication date:
2018-12-17
Acceptance date:
2018-10-22
DOI:
EISSN:
2056-4686
ISSN:
2056-4678
Pubs id:
pubs:930476
URN:
uri:31d9b674-c5a9-4ddd-91ae-1efbee862612
UUID:
uuid:31d9b674-c5a9-4ddd-91ae-1efbee862612
Local pid:
pubs:930476

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP